AcquisitionsMay 18, 2026, 04:23 PM
Catheter Precision Completes Flyte Acquisition; Q1 Revenue +200%
AI Summary
Catheter Precision, Inc. reported strong financial results for the first quarter of 2026, with revenue growing 200% year-over-year to $432,000. The company also announced the successful completion of the transformative Flyte acquisition, which established a new high-growth aviation platform and generated a $200,000 monthly revenue run rate within 22 days of post-acquisition operations. The net loss significantly reduced to $1.7 million from $4.0 million in Q1 2025, driven by revenue growth and operating discipline.
Key Highlights
- Catheter Precision completed the transformative acquisition of Flyte, establishing a new aviation platform.
- Q1 2026 revenue increased 200% year-over-year to $432,000.
- Medical device segment revenue grew approximately 73% in Q1 2026.
- Flyte generated a $200,000 monthly revenue run rate within 22 days post-acquisition.
- Flyte's fleet scaled from 1 to 3 aircraft, with 2 additional jets expected by end of Q2 2026.
- Net loss reduced to $1.7 million in Q1 2026, compared to $4.0 million in Q1 2025.
- Company's medical device products are now utilized in 15 countries worldwide.
Price Impact
More from VTAK